We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Reckitt Benckiser PLC (PK) | USOTC:RBGLY | OTCMarkets | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.08 | 0.69% | 11.66 | 11.65 | 11.67 | 11.6875 | 11.66 | 11.68 | 55,918 | 14:59:23 |
By Michael Susin
Reckitt Benckiser Group PLC reported on Wednesday a better-than-expected swing to pretax profit in 2022 on the back of lower costs and raised its dividend payout.
The consumer-goods company--which houses Dettol, Harpic and Durex among its brands--posted a pretax profit 3.07 billion pounds ($3.69 billion), compared with a loss of GBP260 million in the year-earlier period.
Adjusted operating profit was GBP3.44 billion from GBP2.94 billion a year ago and compared with a consensus of GBP3.42 billion taken from the company's website.
Revenue came in at GBP14.45 billion from GBP13.23 billion the prior year. A consensus estimate taken from the company's website had forecast Reckitt's revenue at GBP14.41 billion.
The company's net revenue on a like-for-like basis grew 7.6%, above the market forecast of 7.5%, supported by broad-based growth.
For the year ahead the company expects like-for-like revenue growth of mid-single digits, an adjusted operating margin to be in line with or slightly above 2022 levels.
The board declared an interim dividend of 183.3 pence a share, compared with 174.6 pence declared the previous year.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
March 01, 2023 02:35 ET (07:35 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Reckitt Benckiser (PK) Chart |
1 Month Reckitt Benckiser (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions